Publications by authors named "Dominic Jack"

Claim this Profile
E
Effect of Cladribine Tablets on the Pharmacokinetics of a Combined Oral Contraceptive in Pre-Menopausal Women With Relapsing Multiple Sclerosis.
Robert Hermann, Kerstin Hellwig, Sumedh Gaikwad, Andrew Galazka, Afrim Bytyqi, Dominic Jack

Clin Transl Sci· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferences and Perspectives of Specialist Multiple Sclerosis Nurses and Patients with Multiple Sclerosis Regarding the New RebiSmart 3.0 Autoinjector versus Other Assistive Devices.
Sridevi S Colten, Elisabetta Verdun di Cantogno, Dominic Jack

Med Devices (Auckl)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of the RebiSmart Electromechanical Autoinjector to Improve Usability in Support of Adherence to Subcutaneous Interferon Beta-1a Therapy for People Living with Multiple Sclerosis.
Yu-Ting Lin, Tamara Will, Charlotte Wickham, Petra Boeree, Dominic Jack

Patient Prefer Adherence· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The spatio-temporal relationship between concurrent lesion and brain atrophy changes in early multiple sclerosis: A post-hoc analysis of the REFLEXION study.
Giordano Gentile, Rozemarijn M Mattiesing, Iman Brouwer, Ronald A van Schijndel, Bernard M J Uitdehaag, Dominic Jack

Neuroimage Clin· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of adherence to, and persistence with, an electromechanical autoinjector for subcutaneous interferon beta-1a injections for multiple sclerosis treatment over 3 years.
Francesco Piras, Lilian Arnaud, Eric Henninger, Matthew Keiser, Andrea Seitzinger, Dominic Jack

Expert Opin Drug Deliv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of cladribine tablets in people with more active multiple sclerosis: a plain language summary.
Patrick Vermersch, Andrew Galazka, Fernando Dangond, Doris Damian, Schiffon L Wong, Dominic Jack

Neurodegener Dis Manag· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease stability over five years in people with multiple sclerosis treated with cladribine tablets: a plain language summary.
Gavin Giovannoni, Giancarlo Comi, Kottil Rammohan, Peter Rieckmann, Fernando Dangond, Dominic Jack

Neurodegener Dis Manag· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The spatio-temporal relationship between white matter lesion volume changes and brain atrophy in clinically isolated syndrome and early multiple sclerosis.
Rozemarijn M Mattiesing, Giordano Gentile, Iman Brouwer, Ronald A van Schijndel, Bernard M J Uitdehaag, Dominic Jack

Neuroimage Clin· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability of no evidence of disease activity-3 (NEDA-3) in patients receiving cladribine tablets: The CLARITY extension study.
Gavin Giovannoni, Barry A Singer, Delphine Issard, Dominic Jack, Patrick Vermersch

Mult Scler· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution from a first clinical demyelinating event to multiple sclerosis in the REFLEX trial: Regional susceptibility in the conversion to multiple sclerosis at disease onset and its amenability to subcutaneous interferon beta-1a.
Marco Battaglini, Hugo Vrenken, Riccardo Tappa Brocci, Giordano Gentile, Ludovico Luchetti, Dominic Jack

Eur J Neurol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Side effects that occurred early in people with multiple sclerosis during the first year of treatment with cladribine tablets: a plain language summary.
Jiwon Oh, Bryan Walker, Gavin Giovannoni, Dominic Jack, Fernando Dangond

Neurodegener Dis Manag· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Family planning in people with multiple sclerosis: a plain language summary.
Simona Bonavita, Luigi Lavorgna, Hilary Worton, Dominic Jack

Neurodegener Dis Manag· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acting centrally or peripherally: A renewed interest in the central nervous system penetration of disease-modifying drugs in multiple sclerosis.
Jorge Correale, Mario Javier Halfon, Dominic Jack, Adrián Rubstein, Andrés Villa

Mult Scler Relat Disord· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of COVID-19 among patients treated with subcutaneous interferon beta-1a for multiple sclerosis.
Mark S Freedman, Dominic Jack, Zuzana Murgašová, Milorad Todorović, Andrea Seitzinger

Mult Scler Relat Disord· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Disease Stability Assessed by the Expanded Disability Status Scale in Patients Treated with Cladribine Tablets 3.5 mg/kg for Relapsing Multiple Sclerosis: An Exploratory Post Hoc Analysis of the CLARITY and CLARITY Extension Studies.
Gavin Giovannoni, Giancarlo Comi, Kottil Rammohan, Peter Rieckmann, Fernando Dangond, Dominic Jack

Adv Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment-emergent adverse events occurring early in the treatment course of cladribine tablets in two phase 3 trials in multiple sclerosis.
Jiwon Oh, Bryan Walker, Gavin Giovannoni, Dominic Jack, Fernando Dangond

Mult Scler J Exp Transl Clin· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 in patients with multiple sclerosis treated with cladribine tablets: An update.
Dominic Jack, Doris Damian, Axel Nolting, Andrew Galazka

Mult Scler Relat Disord· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Family Planning Decision Making in People With Multiple Sclerosis.
Simona Bonavita, Luigi Lavorgna, Hilary Worton, Susan Russell, Dominic Jack

Front Neurol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudy.
Nathaniel Lizak, Suzanne Hodgkinson, Ernest Butler, Jeannette Lechner-Scott, Mark Slee, Dominic Jack

Mult Scler· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of cladribine tablets in high disease activity patients with relapsing multiple sclerosis: analysis of subgroups with and without prior disease-modifying drug treatment.
Patrick Vermersch, Andrew Galazka, Fernando Dangond, Doris Damian, Schiffon L Wong, Dominic Jack

Curr Med Res Opin· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study.
Mark S Freedman, Patricia K Coyle, Giancarlo Comi, Susan L Scarberry, Doris Damian, Dominic Jack

Mult Scler J Exp Transl Clin· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Favorable outcomes after COVID-19 infection in multiple sclerosis patients treated with cladribine tablets.
Dominic Jack, Axel Nolting, Andrew Galazka

Mult Scler Relat Disord· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes.
Nicola De Stefano, Giancarlo Comi, Ludwig Kappos, Mark S Freedman, Chris H Polman, Dominic L Jack

J Neurol Neurosurg Psychiatry· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient subgroup analyses of the treatment effect of subcutaneous interferon β-1a on development of multiple sclerosis in the randomized controlled REFLEX study.
Mark S Freedman, Nicola De Stefano, Frederik Barkhof, Chris H Polman, Giancarlo Comi, Dominic L Jack

J Neurol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severity of meningococcal disease associated with genomic bacterial load.
Tom Darton, Malcolm Guiver, Simone Naylor, Dominic L Jack, Edward B Kaczmarski

Clin Infect Dis· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis